Author:
de Groot Daniel,Spanjaard Aldo,Shah Ronak,Kreft Maaike,Morris Ben,Lieftink Cor,Catsman Joyce J.I.,Ormel Shirley,Ayidah Matilda,Pilzecker Bas,Buoninfante Olimpia Alessandra,van den Berk Paul C.M.,Beijersbergen Roderick L.,Jacobs Heinz
Abstract
ABSTRACTDNA damage tolerance (DDT) enables replication to continue in the presence of fork stalling lesions. To determine the molecular and genomic impact of a global DDT defect, we studiedPcnaK164R/-;Rev1-/-compound mutants. Double mutant (DM) cells displayed increased replication stress, hypersensitivity to genotoxic agents, replication speed, and repriming. A whole genome CRISPR-Cas9 screen revealed a strict reliance of DM cells on the CST complex, where CST promotes fork stability. Whole genome sequencing indicated that this DM DDT defect favors the generation of large, replication-stress inducible deletions of 0.4-4.0kbp, defined as type 3 deletions. Junction break sites of these deletions revealed preferential microhomology preferences of 1-2 base pairs, differing from the smaller type 1 and type 2 deletions. These differential characteristics suggest the existence of molecularly distinct deletion pathways. Type 3 deletions are abundant in human tumors, can dominate the deletion landscape and are associated with DNA damage response status and treatment modality. Our data highlight the essential contribution of the DDT system to genome maintenance and type 3 deletions as mutational signature of replication stress. The unique characteristics of type 3 deletions implicate the existence of a novel deletion pathway in mice and humans that is counteracted by DDT.
Publisher
Cold Spring Harbor Laboratory